Kala Pharmaceuticals Secures $22,500,000 Series B Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b0fbf77d-514b-49d0-9035-8570b349d194
Date
4/23/2014
Company Name
Kala Pharmaceuticals
Mailing Address
100 Beaver St. Waltham, MA 02453 USA
Company Description
Kala Pharmaceuticals, Inc. is a biotechnology company founded upon a proprietary drug delivery technology. By utilizing this unique technology, Kala aims to address unmet therapeutic needs of various diseases and conditions in a fundamentally novel way.
Website
http://www.kalarx.com
Transaction Type
Venture Equity
Transaction Amount
$22,500,000
Transaction Round
Series B
Proceeds Purposes
The proceeds from the financing will be used to advance clinical development of the company’s loteprednol etabonate MPP (LE-MPP) program.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor